GSK’s six-monthly triple-action investigational antisense oligonucleotide (ASO) candidate has demonstrated a clinically and statistically significant functional cure in chronic hepatitis…
Sanofi has agreed to acquire hepatitis B vaccine manufacturer Dynavax for an equity value of around $2.2bn, bolstering the former's…
Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option for HIV, offering…
The US Centers for Disease and Prevention (CDC) no longer recommends that all US newborns receive the hepatitis B vaccine,…
Approvals in the US for a pair of new oral antibiotics for gonorrhoea represent a significant improvement in efforts to…
Mirum Pharmaceuticals has agreed to acquire Bluejay Therapeutics in a deal worth up to $820m, adding a Phase III liver…
The World Health Organization (WHO) has called for access expansion to newly approved human immunodeficiency virus (HIV) medication amid “sharp…
Merck & Co (MSD) has taken the first of two possible plunges in its ongoing collaboration with Evaxion, gaining the…
Bavarian Nordic has launched its chikungunya vaccine, Vimkunya, in the UK. This follows the sharp rise in travel-related disease incidences…
England's National Health Service (NHS) will offer the chickenpox vaccine to children from January 2026, marking the first time the…
